Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis.

Tumminello Fm; Badalamenti G; Incorvaia L; Fulfaro F; Crescimanno M; Flandina C; Gebbia N; Leto C

Risultato della ricerca: Paper

Abstract

Cathepsin K serum levels were determinated in patients with bone metastases from breast cancer or prostate cancer in therapy with zoledronic acid or in patients or in patients with located breast or prostate cancer end in patients with non malignant diseases and in healthy blood. donors (control group). Cathepsin K serum levels were significantly more eleved in healthy subjects or in patients with peimary osteoporosis. Furthermore, the administration of Zoledronic acid to patients with metastatic bome disease from breast or prostate cancer, induced a marked increase of Cathepsin K serum levels.
Lingua originaleEnglish
Stato di pubblicazionePublished - 2007

Fingerprint

zoledronic acid
Cathepsin K
Neoplasm Metastasis
Bone and Bones
Prostatic Neoplasms
Breast Neoplasms
Serum
Osteoporosis
Healthy Volunteers
Tissue Donors

Cita questo

Tumminello Fm; Badalamenti G; Incorvaia L; Fulfaro F; Crescimanno M; Flandina C; Gebbia N; Leto C (2007). Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis..

Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis. / Tumminello Fm; Badalamenti G; Incorvaia L; Fulfaro F; Crescimanno M; Flandina C; Gebbia N; Leto C.

2007.

Risultato della ricerca: Paper

Tumminello Fm; Badalamenti G; Incorvaia L; Fulfaro F; Crescimanno M; Flandina C; Gebbia N; Leto C 2007, 'Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis.'.
Tumminello Fm; Badalamenti G; Incorvaia L; Fulfaro F; Crescimanno M; Flandina C; Gebbia N; Leto C. Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis.. 2007.
Tumminello Fm; Badalamenti G; Incorvaia L; Fulfaro F; Crescimanno M; Flandina C; Gebbia N; Leto C. / Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis.
@conference{afbe7ad6412f4fd19e0011360f20d16c,
title = "Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis.",
abstract = "Cathepsin K serum levels were determinated in patients with bone metastases from breast cancer or prostate cancer in therapy with zoledronic acid or in patients or in patients with located breast or prostate cancer end in patients with non malignant diseases and in healthy blood. donors (control group). Cathepsin K serum levels were significantly more eleved in healthy subjects or in patients with peimary osteoporosis. Furthermore, the administration of Zoledronic acid to patients with metastatic bome disease from breast or prostate cancer, induced a marked increase of Cathepsin K serum levels.",
keywords = "zoledronic acid, cathepsin k, bone metastases",
author = "{Tumminello Fm; Badalamenti G; Incorvaia L; Fulfaro F; Crescimanno M; Flandina C; Gebbia N; Leto C} and Nicolo' Gebbia and Tumminello, {Francesca Maria} and Marilena Crescimanno and Carla Flandina and Gaetano Leto and Giuseppe Badalamenti and Lorena Incorvaia",
year = "2007",
language = "English",

}

TY - CONF

T1 - Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis.

AU - Tumminello Fm; Badalamenti G; Incorvaia L; Fulfaro F; Crescimanno M; Flandina C; Gebbia N; Leto C

AU - Gebbia, Nicolo'

AU - Tumminello, Francesca Maria

AU - Crescimanno, Marilena

AU - Flandina, Carla

AU - Leto, Gaetano

AU - Badalamenti, Giuseppe

AU - Incorvaia, Lorena

PY - 2007

Y1 - 2007

N2 - Cathepsin K serum levels were determinated in patients with bone metastases from breast cancer or prostate cancer in therapy with zoledronic acid or in patients or in patients with located breast or prostate cancer end in patients with non malignant diseases and in healthy blood. donors (control group). Cathepsin K serum levels were significantly more eleved in healthy subjects or in patients with peimary osteoporosis. Furthermore, the administration of Zoledronic acid to patients with metastatic bome disease from breast or prostate cancer, induced a marked increase of Cathepsin K serum levels.

AB - Cathepsin K serum levels were determinated in patients with bone metastases from breast cancer or prostate cancer in therapy with zoledronic acid or in patients or in patients with located breast or prostate cancer end in patients with non malignant diseases and in healthy blood. donors (control group). Cathepsin K serum levels were significantly more eleved in healthy subjects or in patients with peimary osteoporosis. Furthermore, the administration of Zoledronic acid to patients with metastatic bome disease from breast or prostate cancer, induced a marked increase of Cathepsin K serum levels.

KW - zoledronic acid, cathepsin k, bone metastases

UR - http://hdl.handle.net/10447/13126

M3 - Paper

ER -